投稿についてもっと詳しく Cilcare strengthens its therapeutic pipeline with two new exclusive licensing agreements with Sanofi
Cilcare-Sanofi licensing agreements

Cilcare strengthens its therapeutic pipeline with two new exclusive licensing agreements with Sanofi

CIL005 and CIL006 extend Cilcare’s pipeline to new mechanisms of hearing loss and new patient populationsMontpellier, France, November 16, 2026 – Cilcare, a biotechnology company pioneering auditory science, today announced…

続きを読むCilcare strengthens its therapeutic pipeline with two new exclusive licensing agreements with Sanofi